Skip to content

13F-HR filed by Endurant Capital Management LP

Endurant Capital Management LP filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 56 holding rows worth $1,824,008,000.

Accession
0001633055-20-000003
Filed
2020-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 56 entries on the cover page, a total value of $1,824,008,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,824,008,000 with VALUE read as thousands by filing date, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ISHARES TR464287630RUS 2000 VAL ETF108,600$1,554,935,000thousands by filing dateput
SPY78462F103SHS77,600$23,928,000thousands by filing dateput
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS1,396,795$18,158,000thousands by filing date
EVOLENT HEALTH INC30050BAB7NOTE 2.000%12/020,156,000$17,649,000thousands by filing date
SI BONE INC825704109COM743,380$11,849,000thousands by filing date
Johnson & Johnson478160104COM83,879$11,796,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock170,057$10,807,000thousands by filing date
ZOETIS INC CL A98978V103Stock73,200$10,031,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock183,249$9,403,000thousands by filing date
ENCOMPASS HEALTH CORP COM29261A100Stock141,195$8,744,000thousands by filing date
Elevance Health, Inc.036752103COM30,028$7,897,000thousands by filing date
Medtronic PlcG5960L103COM75,828$6,953,000thousands by filing date
Cigna Corporation125523100COM36,122$6,778,000thousands by filing date
ICU MED INC44930G107COM35,556$6,553,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW37,915$6,298,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM755,330$6,292,000thousands by filing date
AbbVie,Inc.00287Y109COM62,615$6,148,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock46,038$5,495,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock677,823$5,484,000thousands by filing date
HMS HLDGS CORP40425J101COM161,914$5,244,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR99,869$5,098,000thousands by filing date
SELECTA BIOSCIENCES INC816212104COM1,779,328$5,053,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR483,103$4,836,000thousands by filing date
HOLOGIC INC436440101COM81,789$4,662,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock403,793$4,224,000thousands by filing date
HILL ROM HLDGS INC431475102COM35,604$3,909,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock140,184$3,861,000thousands by filing date
Boston Scientific Corporation101137107COM106,338$3,734,000thousands by filing date
CALLIDITAS THERAPEUTICS AB SPONSERED13124Q106ADS160,218$3,717,000thousands by filing date
BAXTER INTL INC071813109COM42,439$3,654,000thousands by filing date
SYNEOS HEALTH INC87166B102CL A54,577$3,179,000thousands by filing date
MOLECULAR TEMPLATES INC608550109COM229,817$3,169,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock1,728,787$2,801,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock28,937$2,592,000thousands by filing date
MCKESSON CORP COM58155Q103Stock15,942$2,446,000thousands by filing date
MUSTANG BIO INC62818Q104COM768,471$2,444,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock24,178$2,246,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock15,773$2,238,000thousands by filing date
Bristol-Myers Squibb Company110122108COM36,109$2,123,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM60,892$2,089,000thousands by filing date
PRINCIPIA BIOPHARMA INC74257L108COM30,395$1,817,000thousands by filing date
BIO RAD LABS INC090572207CL A3,505$1,582,000thousands by filing date
DENTSPLY SIRONA INC24906P109COM35,059$1,545,000thousands by filing date
BECTON DICKINSON & CO075887109COM6,080$1,455,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock237,174$1,447,000thousands by filing date
SENSEONICS HLDGS INC81727UAA3NOTE 5.250% 2/01,500,000$1,260,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM156,005$1,211,000thousands by filing date
ADAPTHEALTH CORP00653Q102COMMON STOCK71,000$1,143,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM19,677$998,000thousands by filing date
ZOGENIX INC.98978L204Common Stock29,575$799,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM38,494$591,000thousands by filing date
INSULET CORP COM45784P101Stock2,465$479,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM4,148$466,000thousands by filing date
GENOCEA BIOSCIENCES INC372427401COMMON STOCK119,979$276,000thousands by filing date
VAXCYTE INC COM92243G108Stock6,827$216,000thousands by filing date
ADC THERAPEUTICS SAH0036K147COMMON STOCK4,410$206,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001633055-20-000003this filing2020-08-14acceptance time not in the bulk data set